tm logo
ANAVEX
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 19 Mar 2024

Last Applicant/ Owned by

630 5th Avenue, 20th Floor

New York

NY

10111

Serial Number

86768671 filed on 25th Sep 2015

Registration Number

5273729 registered on 29th Aug 2017

in the Principal Register

Correspondent Address

Matthew Smith

Matthew Smith

PO BOX 140310

Kansas City,MO 64114-0310

Filing Basis

1. filed as use application

2. use application currently

Disclaimer

NO DATA

ANAVEX

Pharmaceutical preparations for the treatment of neurological conditions including Alzheimer's disease

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment of neurological conditions including Alzheimer's disease


First Use Date in General

01st Jan 2007

First Use Date in Commerce

01st Jan 2007

Mark Details


Serial Number

No 86768671

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 085102585135

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
19th Mar 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
19th Mar 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
18th Mar 2024TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
15th Feb 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
15th Feb 2024POST REGISTRATION ACTION MAILED - SEC. 8 & 15
29th Aug 2023TEAS SECTION 8 & 15 RECEIVED
29th Aug 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
29th Aug 2017REGISTERED-PRINCIPAL REGISTER
13th Jun 2017PUBLISHED FOR OPPOSITION
13th Jun 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED